Sumatriptan 100 mg

DRUG5 trials

Sponsors

Montefiore Medical Center, University of Washington, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Allodynic Therapeutics, Inc, Cambridge University Hospitals NHS Foundation Trust

Conditions

MigraineMigraine With and Without AuraMigraine With or Without AuraOverweightPost-traumatic HeadachePrimary Headache DisorderTension-type Headache

Early Phase 1

Sumatriptan and Glucose

Cambridge University Hospitals NHS Foundation TrustOverweight

Start: 2021-01-04End: 2021-06-25Target: 12Updated: 2020-12-30

Phase 2

Sumatriptan as Treatment for Post-traumatic Headache

CompletedNCT01854385

University of WashingtonPost-traumatic Headache

Start: 2013-06-30End: 2018-02-28Updated: 2022-01-11

Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea

CompletedNCT03185143

Allodynic Therapeutics, IncMigraine With and Without Aura

Start: 2017-06-27End: 2018-05-07Updated: 2021-04-14

Phase 3

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

CompletedNCT01986088

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Migraine With or Without Aura

Start: 1996-11-30End: 1998-01-31Updated: 2021-01-28

Phase 4

Comparing Naproxen to Sumatriptan for Emergency Headache Patients

CompletedNCT00449787

Montefiore Medical CenterMigraine, Primary Headache Disorder, Tension-type Headache

Start: 2007-03-31End: 2009-07-31Updated: 2018-05-31

Related Papers

Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study

Headache The Journal of Head and Face Pain2024-08-13